Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / July / AI Model Predicts Inpatient Hypoglycemia
Endocrinology Bioinformatics Point of care testing Clinical care Screening and monitoring Technology and innovation

AI Model Predicts Inpatient Hypoglycemia

Real-time tool could help hospitals identify patients at risk before dangerous blood glucose events occur

07/08/2026 News 2 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Poll
  • Top Institutions

Share

Clinical Report: AI Model Predicts Inpatient Hypoglycemia

Overview

A deep learning model developed by Cedars-Sinai can predict inpatient hypoglycemia up to 24 hours in advance by analyzing electronic health record data. This model utilizes a combination of clinical information to generate risk predictions.

Background

Inpatient hypoglycemia is a significant concern in hospital settings, often leading to adverse patient outcomes. Current guidelines emphasize the importance of decision-support tools in managing dysglycemia effectively.

Data Highlights

Study PeriodAdmissions AnalyzedPrediction Timeframe
2014-2025143,124Up to 24 hours

Key Findings

  • The model updates risk predictions every four hours for patients on glucose-lowering treatment.
  • Laboratory results were among the strongest predictors of hypoglycemia risk, second only to medication data.
  • Recent insulin administration and previous hypoglycemia episodes were key factors influencing risk predictions.
  • The model maintained consistent performance across different demographic groups during prospective validation.
  • Integration into electronic health record systems could facilitate treatment adjustments.

Clinical Implications

The model's ability to predict hypoglycemia may assist in identifying high-risk patients.

Conclusion

The development of this predictive model represents a notable use of artificial intelligence for inpatient care.

Related Resources & Content

  1. Cedars-Sinai Medical Center, npj Digital Medicine, 2026 -- Development and prospective evaluation of a real-time deep learning model for inpatient hypoglycemia prediction
  2. American Diabetes Association, Diabetes Care, 2026 -- Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026
  3. CMS, eCQI Resource Center, 2025 -- Hospital Harm - Severe Hypoglycemia
  4. aace endocrine ai — AI tool predicts hypoglycemia risk pre-exercise
  5. conexiant — AI Model Finds Hidden Risk Signals in CGM Data
  6. aace endocrine ai — AACE 2026: How machine learning models predict hemoglobin A1c response
  7. aace endocrine ai — Model shows promise for personalized insulin support
  8. AI tool predicts hypoglycemia risk pre-exercise
  9. AI Model Finds Hidden Risk Signals in CGM Data
  10. AACE 2026: How machine learning models predict hemoglobin A1c response
  11. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  12. Hospital Harm - Severe Hypoglycemia | eCQI Resource Center
  13. Development and prospective evaluation of a real-time deep learning model for inpatient hypoglycemia prediction | npj Digital Medicine

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

What’s New in Infectious Disease? (December 2021)
Point of care testing
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Resisting Resistance
Point of care testing
Resisting Resistance

October 21, 2016

1 min read

Rapid, affordable tests to spot bacterial infections could reduce antibiotic overprescription in resource-limited settings

HIV/AIDS: A Shifting Epidemic
Point of care testing
HIV/AIDS: A Shifting Epidemic

April 4, 2022

1 min read

HIV diagnoses in heterosexual people in the UK have overtaken those in gay and bisexual men

Career Snapshots with Bamidele Farinre
Point of care testing
Career Snapshots with Bamidele Farinre

April 20, 2022

3 min read

Michael Schubert interviews Bamidele Farinre about her work in mobile laboratory testing

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.